Axsome Therapeutics, Inc.
COMPOSITIONS FOR DELIVERY OF REBOXETINE

Last updated:

Abstract:

Described herein are methods for the administration of reboxetine, or a pharmaceutically acceptable salt thereof, to a human being in need thereof, resulting in a first maximum plasma concentration and a second maximum plasma concentration, wherein the two maxima are separated by a time period of about 2 hours to about 6 hours.

Status:
Application
Type:

Utility

Filling date:

17 Jul 2019

Issue date:

19 Dec 2019